×
Pulmonx Receivables 2019-2025 | LUNG
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Pulmonx receivables from 2019 to 2025. Receivables can be defined as the total amount of collectibles for a company
View More
Pulmonx Receivables 2019-2025 | LUNG
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Pulmonx receivables from 2019 to 2025. Receivables can be defined as the total amount of collectibles for a company
Related Stocks
Company Name
Market
Cap
Veeva Systems (VEEV)
$44B
Tempus AI (TEM)
$13.2B
Doximity (DOCS)
$12.7B
Hims & Hers Health (HIMS)
$9.6B
IRhythm Technologies (IRTC)
$5.5B
Hinge Health (HNGE)
$4.4B
Privia Health (PRVA)
$2.8B
Inspire Medical Systems (INSP)
$2.8B
Heartflow (HTFL)
$2.6B
Phreesia (PHR)
$1.9B
Enovis (ENOV)
$1.8B
10x Genomics (TXG)
$1.7B
Omnicell (OMCL)
$1.5B
Schrodinger (SDGR)
$1.4B
Azenta (AZTA)
$1.4B
Clover Health Investments (CLOV)
$1.3B
Claritev (CTEV)
$1.1B
Evolent Health (EVH)
$1.1B
Fulgent Genetics (FLGT)
$679M
Zepp Health (ZEPP)
$652M
Veradigm (MDRX)
$531M
Standard BioTools (LAB)
$481M
Talkspace (TALK)
$445M
Butterfly Network (BFLY)
$405M
Carlsmed (CARL)
$354M
TruBridge (TBRG)
$300M
Outset Medical (OM)
$247M
Health Catalyst (HCAT)
$239M
SOPHiA GENETICS SA (SOPH)
$234M
Nyxoah SA (NYXH)
$213M